Calpain inhibitors exhibit moderate to good antiproliferative activity in vitro against melanoma cell lines (A-375 and B-16F1) and PC-3 prostate cancer cells; additionally, one member of this group (compound 3) inhibits 80% of DU-145 cell invasion at a concentration of 2 μM in a Matrigel cell invasion assay.